(PharmaNewsWire.Com, March 16, 2017 ) The Global Protein Expression was worth $1.45 billion in 2016 and estimated to be growing at a CAGR of 9.50%, to reach $2.28 billion by 2021. Protein expression refers to the process in which proteins are altered, synthesized and controlled in living organisms.
Proteins are regulated and manufactured depending upon the functional need in the host cell. Biotechnology based companies are developing novel therapeutics with minimal side effects and thereby creating a huge market for Protein expression.
The growth of the Protein Expression market is majorly driven by factors such as rise in the R&D movement in the pharma division, prospects in the field of proteomics, rising incidences of chronic diseases, and initiatives taken by the governments. Growth in the biologics market will also boost the market growth. However, issues such as high product development costs and complex Regulatory Environment are restraining the growth of the market.
The Global Protein Expression market is segmented based on Expression System, Product, Application and End User. The market for Protein Expression, on the basis of Expression System, is classified into Yeast Expression, Insect Expression, Cell-Free Expression, Bacterial Expression, Algal Expression, and Mammalian Expression. The Bacterial Expression system segment holds the largest share of the market, while mammalian expression system segment is projected to grow at the highest CAGR during the forecast period, due to the increasing demand of therapeutic proteins essential for human treatment.
On the basis of Product, the global Protein Expression market is segmented into Reagents, Services, Instruments, and Others. Due to the constant consumption of reagents required for the transfection and maintenance of capable host cells, reagents lead the market in the product segment, whereas the services segment of the protein expression market is anticipated to grow at the highest CAGR during the forecast period. On the basis of Application, the global Protein Expression market is segmented into Industrial Proteins, Cell Culture, Research, Therapeutic Proteins, Transfection technologies & Others. On the basis of End User, the global Protein Expression market is segmented into Biotechnology, Pharmaceutics, and Academia. Pharmaceutical sector leads the end user segment of the Protein Expression market.
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America accounts for the largest share of the protein expression market and is projected to lead the global market in the coming years, on account of the large research budgets and highly evolved pharmaceutical industry in this region. On the other hand, the emerging markets of Asia-Pacific region, most significantly India and China, account for the highest growth rate owing to the increased expenditure in R&D and huge untapped potential of these markets.
The major companies dominating this market are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
